Study of Fluticasone Propionate/Salmeterol DISKUS Combination and Fluticasone Propionate (FP) DISKUS in Treatment of Subjects with Asthma - Trial 2015-004892-61

Name: Clinical Trial 2015-004892-61
Creator: GlaxoSmithKline Research & Development Ltd
Keywords: Asthma, clinical trial

Access comprehensive clinical trial information for 2015-004892-61 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Asthma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-004892-61

Trial Details

EU Clinical Trials Register • 2015-004892-61

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Study of Fluticasone Propionate/Salmeterol DISKUS Combination and Fluticasone Propionate (FP) DISKUS in Treatment of Subjects with Asthma

Study Focus

Disease/Condition

Asthma

Sponsor & Location

Primary Sponsor

GlaxoSmithKline Research & Development Ltd

Funder

GlaxoSmithKline

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

Comparison of improvement in lung function as measured by FEV1 between ADVAIR DISKUS 250/50 mcg BID vs FLOVENT DISKUS mcg BID over 52 weeks

ICD-10 Classifications

Asthma

Asthma, unspecified

Nonallergic asthma

Mixed asthma

Predominantly allergic asthma

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-004892-61

Type

Non-Device Trial